Dawn Health set out to revolutionize digitalization of the global life science industry with new investment round

COPENHAGEN, Denmark, Dec. 1, 2021 /PRNewswire/ -- Dawn Health, a global leader in digital health, has received a USD 25 million investment from a consortium of highly experienced investors. The consortium counts Chr. Augustinus Fabrikker, Vaekstfonden - The Danish Growth Fund, and Lars Marcher. The investment will further accelerate the growth of Dawn Health in the rapidly expanding market for digital therapeutics and software as a medical device. With the investment Dawn Health is set out to transform the global health tech industry, and Denmark has a unique potential within this sector, Daniel Gewecke Daugaard, Founder & CEO of Dawn Health explains:

"Throughout the last century, Denmark has established an impressive life science industry. At the doorstep to 2022, digital health is disrupting the traditional delivery models of healthcare services - responding to the needs of digital citizens demanding change and empowerment. In Dawn Health we are determined to spearhead this digital revolution and co-create a new normal for patients with serious chronic diseases. Our new investment will pave the way for development of ground-breaking digital health innovations - executed in close collaboration with a broad portfolio of international life science partners."  

Since 2016, Dawn Health has established a unique process landscape and certified quality management system that allows for agile development of highly regulated software products. This capability has fueled rapid growth and caries the potential to make Dawn Health a global leader in development of life-changing digital health software products targeting patients with chronic diseases. Over the next 4 years Dawn Health will deploy an ambitious investment strategy to further accelerate its growth and international footprint. And this has caught the eyes of the investors:

"Digitization of medical devices is a global megatrend, and Dawn has both the knowledge and ambitions to play an important role. We are very impressed with the team behind Dawn Health, and we look forward to help realizing the great potential of digital healthcare products for the benefit of us all. Investments in ambitious Danish startups are an important part of Chr. Augustinus Fabrikker's scale investment strategy, and we have allocated more than DKK 1 billion to new innovative companies with an international outlook such as Dawn Health", says Claus Gregersen, CEO of Chr. Augustinus Fabrikker.

In 2022, Dawn Health plans to receive certification to function as a legal manufacturer of medical devices on behalf of partners in the life science industry. In tandem, Dawn Health is developing a generic platform for accelerated delivery of regulated medical device software products. Combined, these strategic capabilities aim to revolutionize digitalization in the life science industry by reducing the development cycle of regulated digital health products from years to months - a strategic capability that will drive increased competitiveness and result in improved patient outcomes derived from medicine working in tandem with emerging technologies.

"Denmark has a unique potential to create new market leaders within the global health tech industry, and Dawn Health is a prime example of this. Digitizing the health sector is crucial for creating a stronger and better global healthcare system. And we need innovative companies like Dawn Health to drive this transformation. That is why we are excited to be able to back Dawn Health's journey towards becoming a global market leader, building on their strong roots in Denmark and the local ecosystem", says Rolf Kjærgaard, CEO of Vaekstfonden.

The first international customers have already embarked on Dawn Health's regulated software platform, and next year the company aims to double its workforce while maintaining ambitions to reach triple-digit growth rates. Following the investment, Lars Marcher will assume the role as Chairman of the Board of Directors, accompanied by John Rubek Lauritsen from Chr. Augustinus Fabrikker and Mads Lacoppidan from Vaekstfonden.

Investor Lars Marcher joins the company as Chairman of the Board and has high expectations to the future of Dawn Health:

"Dawn Health is a unique company with a strong innovation platform with high global scalability in the rapid changing space of digital health. With significant opportunities, strong leadership and dedicated employees I look forward to the transformative journey together with my highly experienced board colleagues."

The new investors will join the existing owners of Dawn Health, which was founded jointly by Daniel Gewecke Daugaard and provider of NextGen IT services and solutions Trifork in 2016, with a vision to become a global lighthouse for digital health in the life science industry.

"It has been an amazing journey with Dawn Health so far, and we are very pleased to welcome this strong team of investors to help taking Dawn Health to the next level. Together they bring a lot of experience, connections, and insights, which will contribute to accelerate growth even further. We are looking forward to continue to support Dawn Health and to working closely together with the new investors in unfolding the potential of executing on this exciting and rewarding journey", says Jørn Larsen, CEO and founder of Trifork

About Dawn Health

Dawn Health is Europe's leading digital health agency, and a catalyst for spearheading innovation in the healthcare industry. The company specialize in development of software as medical device (SaMD) and digital therapeutics (DTx). Dawn Health employs 60 people across Denmark, Germany, and the UAE. In 2020, Dawn Labs A/S was established to incubate innovative digital health product companies with Dawn Health as Legal Manufacturer. The company's mission is to bring research, care and technology together with the aim of helping 1 million people live longer and better lives by 2030. https://dawnhealth.com/ 

About Chr. Augustinus Fabrikker

Chr. Augustinus Fabrikker is an investment company with a more than 270-year-old history and extensive interests in the Danish business community. As part of a strategy to be a long-term, committed, and value-adding owner, the company's portfolio comprises considerable ownership of successful and iconic Danish businesses such as Tivoli, Gyldendal, Jeudan, Royal Unibrew, Fritz Hansen, including digital health companies such as Corti.ai. Chr. Augustinus Fabrikker is a subsidiary of the Augustinus Foundation, which is among the largest cultural foundations in Denmark. With assets of more than DKK 40 billion Chr. Augustinus Fabrikker is a substantial participant in the Danish business society. The asset base enables Chr. Augustinus Fabrikker to actively reinvest in Danish businesses as well of securing the philanthropic activities of the Augustinus Foundation. https://augustinusfabrikker.dk/en/

About Vaekstfonden

Vaekstfonden is the Danish state's investment fund. In close collaboration with banks and domestic and international private investors, Vaekstfonden discovers and develops the companies that Denmark cannot afford to miss out on. The power of innovation, yield to society, and responsibility are the three signposts that guide Vaekstfonden in finding and choosing new projects. Since 1992, Vaekstfonden has financed more than 11.000 companies for more than DKK 42 billion. https://vf.dk/  

About Trifork

Trifork is a global NextGen IT company that develops innovative software solutions in collaboration with its customers. The company has more than 900 employees, across 57 business units, with offices in 11 countries in Europe and the USA, and works in six business areas: Digital Health, FinTech, Smart Building, Cloud Operations, Cyber Protection and Smart Enterprise. Trifork's research and development takes place in Trifork Labs, where Trifork continuously co-invests and develops technology start-up companies. Trifork is behind the brand, GOTO, which runs a global tech community with over 255,000 subscribers and more than 27 million views on YouTube. www.trifork.com

Contact

Daniel Gewecke Daugaard, Founder & CEO, Dawn Health
[email protected]
+45 93 84 35 37

Lars Marcher, New Chairman of the Board, Dawn Health
[email protected]

Line Gulløv Lundh, Head of Secretariat, Chr. Augustinus Fabrikker Akts. and Augustinus Foundation
[email protected] 
+45 33 14 52 93

Cecilie Idun Andersen, Press Advisor, Vaekstfonden - The Danish Growth Fund
[email protected] 
+45 31 93 05 73

Peter Rørsgaard, CMO, Trifork
[email protected] 
+45 2042 2494

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/dawn-health-a-s/r/dawn-health-set-out-to-revolutionize-digitalization-of-the-global-life-science-industry-with-new-inv,c3463799

The following files are available for download:

SOURCE Dawn Health A/S

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED